Phase II trial of LGT 209 in patients with hypercholesterolaemia.

Trial Profile

Phase II trial of LGT 209 in patients with hypercholesterolaemia.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2013

At a glance

  • Drugs LGT 209 (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2013 Status changed from recruiting to discontinued, based on information in Novartis' 20-F form (http://www.novartis.com/downloads/newsroom/corporate-publications/Novartis-20-F-2012.pdf).
    • 06 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top